Sridhar Regati

Title: Sridhar Regati: Innovator in Pharmaceutical Chemistry

Introduction

Sridhar Regati is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for synthesizing complex compounds. His work is characterized by a focus on achieving high optical purity in chemical preparations.

Latest Patents

Sridhar Regati holds a patent for a method titled "Method for preparing (R)-N-[4-(1-amino-ethyl)-2,6-difluoro-phenyl]-methanesulfonamide." This innovative method allows for the preparation of N-[4-[(1R)-1-[[(R)-(1,1-dimethylethyl)sulfinyl]amino]ethyl]-2,6-difluorophenyl]-methanesulfonamide (INT028-2) with high optical purity. The process involves the selection of Ellman-chiral auxiliaries and the recrystallization and separation of optical isomers. This method enables the production of high-purity compounds at room temperature, significantly reducing the failure rate associated with cryogenic processes.

Career Highlights

Sridhar Regati is currently employed at Amorepacific Corporation, where he continues to apply his expertise in pharmaceutical development. His innovative approaches have contributed to advancements in the industry, particularly in the synthesis of high-quality pharmaceutical compounds.

Collaborations

Sridhar has collaborated with esteemed colleagues, including Byoung Young Woo and Ki-Wha Lee. These partnerships have fostered a collaborative environment that enhances the research and development efforts within the company.

Conclusion

Sridhar Regati's contributions to pharmaceutical chemistry, particularly through his patented methods, highlight his role as an innovator in the field. His work not only advances scientific knowledge but also improves the efficiency of pharmaceutical manufacturing processes.